We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Antidepressants Linked to Implant Failure

By HospiMedica International staff writers
Posted on 21 Mar 2016
A new study finds that antidepressants, commonly used to treat anxiety, pain, and other disorders, may play a role in dental implant failure by inhibiting bone growth.

Researchers at the University of Buffalo (UB; NY, USA) performed a retrospective chart review of 74 patients (41 females/33 males) aged 18 or older who received dental implants in the UB post-doctoral dental clinic between January and August 2014. More...
The study cohort consisted of patients who reported using at least one type of antidepressant, while the control group consisted of patients with no such history. The number of implants received per patient ranged between one and 11, with implant failure defined as loss of at least one implant.

The results showed that six (7.9%) of the patients experienced implant failure, each losing only one implant. The frequency of antidepressant use was higher in patients who experienced implant failure (33.3%) compared to those who did not (11.3%). The odds of implant failure among antidepressant drug users were about four times higher compared to controls, with each year of antidepressant use associated with two-fold increase in the odds of implant failure. The study was presented at the 45th annual American Association for Dental Research (AADR) conference, held during March 2016 in Los Angeles (CA, USA).

“Four of the many known side effects that are reported in the literature are a big concern to us as dentists in regard to oral and bone health,” said study coauthor Latifa Bairam, DDS, MS, of the UB department of restorative dentistry. “Additional side effects of antidepressants include osteoporosis; akathisia, a disorder characterized by the need to be in constant motion, including the head and jaw; bruxism, or teeth grinding; and dryness of the mouth, all of which affect the implant healing process.”

Antidepressants are used for the treatment of major depressive disorder and a range of other conditions, including dysthymia, anxiety disorders, obsessive compulsive disorder (OCD), eating disorders, chronic and neuropathic pain and dysmenorrhoea, snoring, migraine, attention deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders.

Related Links:

University of Buffalo




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.